The limitations of carrier mediated sodium stibogluconate chemotherapy in the BALB/c mouse model of visceral leishmaniasis.

Katharine Carter, T. F. Dolan, James Alexander , Alan Baillie

Research output: Chapter in Book/Report/Conference proceedingChapter

Original languageEnglish
Title of host publicationLiposomes in the therapy of infectious diseases and cancer
EditorsGabriel Lopez-Berestein, Isaiah Fidler
Pages215-225
Number of pages11
Publication statusPublished - 1989

Keywords

  • visceral leishmaniasis
  • mice
  • sodium stibogluconate

Cite this

Carter, K., Dolan, T. F., Alexander , J., & Baillie, A. (1989). The limitations of carrier mediated sodium stibogluconate chemotherapy in the BALB/c mouse model of visceral leishmaniasis. In G. Lopez-Berestein, & I. Fidler (Eds.), Liposomes in the therapy of infectious diseases and cancer (pp. 215-225)